Form 4 for DGX Quest Diagnostics
Accepted 2022-11-03 00:00:00 ET · period of report 2022-11-01 · accession 0001022079-22-000154 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-03 | 2022-11-01 | DGX | Davis J. E. | CEO, Pres, Dir | A - Grant | $0.00 | +14.0K | 80.8K | +21% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-01 | A | A | 13,980 | $0.00 | 80,788 | D | — | — | (F1) Represents an award of restricted share units. |